Skip to main content
. 2016 Sep 6;113(38):10666–10671. doi: 10.1073/pnas.1611481113

Table 2.

Genes affected by Act D or RG7787 using apoptotic array

KLM1 RH16
Symbol Act D RG7787 Comb Act D RG7787 Comb
TNFα 10 147.6 103.1 1.2 6.9 11.2
TNFβ 1.2 7.5 13.4 4.8 2.9 3.5
TNFSF7 (CD70) 2.7 4.1 3.3 1.6 1 2.8
Fas 1.1 2.4 1 5.9 0.1 6.1
TRAILR2/DR5 2.7 8.3 4.6 2 1 3.9
TNFR2 10.5 15.5 8.1 0.5 0.6 0.4
TNFRSF9 (CD137) 4.6 68.8 15.7 0.7 4.5 2.8
TNFRSF7 (CD27) 3.4 0.2 0.2 2.4 0.5 1.8
Caspase-1 0.7 0.3 0.4 15 1.3 13.5
Caspase-10 2.1 1.9 3 3.6 1.5 5.4
Caspase-3 2.9 1.4 3.8 1.8 1.6 2.4
Caspase-5 2.8 0.7 5.6 2.8 1.3 3.5
Caspase-7 3.4 1.1 2.2 1.2 0.9 1.8
Caspase-9 1.9 2.4 3.2 1 3.4 2.4
Bcl-10 2.2 4.3 3.2 2.3 1.9 3.9
BCL2A1 3.4 7.4 21.6 2.1 19.2 22.6
Bim 3.1 0.7 2.3 1.8 0.7 1.7
Bik 1.8 6.1 3.6 2.5 1.1 4.1
CIAP2 4.7 46.3 13.2 8.6 5.7 9.8
GADD45A 4.1 63.1 30 4.5 4.1 21.2
TP53 2.4 5.6 8.8 1.5 1.1 1.6
TP53BP2 1.6 5.8 3.7 1.6 1.7 1.8
RIPK2 2.3 2.9 2.2 3.1 2.4 4.8

KLM1 or RH16 cells were treated with Act D (KLM1, 10 ng/mL; RH16, 5 ng/mL) or RG7787 (KLM1, 100 ng/mL; RH16, 200 ng/mL) for 24 h. Then total RNA was isolated and apoptotic array performed. The numbers are generated using web-based data analysis (Qiagen) by setting the untreated control as 1 and using ACTB, B2M, GAPDH, HPRT1, and RPLP0 as the internal control. The genes that changed over threefold were selected and presented in the table.